1. Resources
  2. Citations Library

Citation Details

You are viewing citation details. You can save or export citation(s) below, access an article, or start a new search.

1–1 of 1 record found matching your query:

Headers act as filters

      1. Author :
        Zhou, Heling; Hallac, Rami R; Lopez, Ramona; Denney, Rebecca; MacDonough, Matthew T; Li, Li; Liu, Li; Graves, Edward E; Trawick, Mary Lynn; Pinney, Kevin G
      2. Title :
        Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and 19F MRI
      3. Type :
        Journal Article
      4. Year :
      5. Publication :
        Am J Nucl Med Mol Imaging
      6. Products :
      7. Volume :
      8. Issue :
      9. Page Numbers :
      10. Research Area :
      11. Keywords :
        Vascular disrupting agents (VDAs),; bioluminescence imaging (BLI),; oximetry,; hypoxia,; 19F MRI,; hexafluorobenzene,; OXi8007,; CA4P; IVIS; IVIS BLI in vivo
      12. Abstract :
        Vascular disrupting agents (VDAs) have been proposed as an effective broad spectrum approach to cancer therapy, by inducing ischemia leading to hypoxia and cell death. A novel VDA (OXi8007) was recently reported to show rapid acute selective shutdown of tumor vasculature based on color-Doppler ultrasound. We have now expanded investigations to noninvasively assess perfusion and hypoxiation of orthotopic human MDA-MB-231/luc breast tumor xenografts following the administration of OXi8007 based on dynamic bioluminescence imaging (BLI) and magnetic resonance imaging (MRI). BLI showed significantly lower signal four hours after the administration of OXi8007, which was very similar to the response to combretastatin A-4P (CA4P), but the effect lasted considerably longer, with the BLI signal remaining depressed at 72 hrs. Meanwhile, control tumors exhibited minimal change. Oximetry used 19F MRI of the reporter molecule hexafluorobenzene and FREDOM (Fluorocarbon Relaxometry using Echo Planar Imaging for Dynamic Oxygen Mapping) to assess pO2 distributions during air and oxygen breathing. pO2 decreased significantly upon the administration of OXi8007 during oxygen breathing (from 122 ± 64 to 34 ± 20 Torr), with further decrease upon switching the gas to air (pO2 = 17 ± 9 Torr). pO2 maps indicated intra-tumor heterogeneity in response to OXi8007, though ultimately all tumor regions became hypoxic. Both BLI and FREDOM showed the efficacy of OXi8007. The pO2 changes measured by FREDOM may be crucial for future study of combined therapy.
      13. URL :
      14. Call Number :
        PKI @ user @ 9130
      15. Serial :